LifeMD Inc (NASDAQ:LFMD) has a beta value of 1.35 and has seen 1.06 million shares traded in the last trading session. The company, currently valued at $274.60M, closed the last trade at $6.34 per share which meant it lost -$0.13 on the day or -2.01% during that session. The LFMD stock price is -103.15% off its 52-week high price of $12.88 and 37.07% above the 52-week low of $3.99. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.74 million shares traded. The 3-month trading volume is 548.40K shares.

The consensus among analysts is that LifeMD Inc (LFMD) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 4 have rated it as a Hold, with 4 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.14.

LifeMD Inc (NASDAQ:LFMD) trade information

Sporting -2.01% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the LFMD stock price touched $6.34 or saw a rise of 5.09%. Year-to-date, LifeMD Inc shares have moved -23.52%, while the 5-day performance has seen it change 14.03%. Over the past 30 days, the shares of LifeMD Inc (NASDAQ:LFMD) have changed 44.25%. Short interest in the company has seen 5.87 million shares shorted with days to cover at 8.92.

Wall Street analysts have a consensus price target for the stock at $12, which means that the shares’ value could jump 47.17% from current levels. The projected low price target is $12.0 while the price target rests at a high of $12.0. In that case, then, we find that the current price level is -89.27% off the targeted high while a plunge would see the stock gain -89.27% from current levels.

LifeMD Inc (LFMD) estimates and forecasts

Figures show that LifeMD Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -19.85% over the past 6 months, with this year growth rate of 18.57%, compared to 4.30% for the industry. Revenue growth from the last financial year stood is estimated to be 34.66%.

7 analysts offering their estimates for the company have set an average revenue estimate of 57.24M for the current quarter. 7 have an estimated revenue figure of 58.79M for the next ending quarter. Year-ago sales stood 44.86M and 44.14M respectively for this quarter and the next, and analysts expect sales will grow by 27.60% for the current quarter and 34.66% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -25.48% over the past 5 years.

LFMD Dividends

LifeMD Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

LifeMD Inc (NASDAQ:LFMD)’s Major holders

Insiders own 15.57% of the company shares, while shares held by institutions stand at 40.50% with a share float percentage of 47.97%. Investors are also buoyed by the number of investors in a company, with LifeMD Inc having a total of 135.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 2.34 million shares worth more than $16.03 million. As of 2024-06-30, BLACKROCK INC. held 5.9546% of shares outstanding.

The other major institutional holder is VANGUARD GROUP INC, with the holding of over 1.52 million shares as of 2024-06-30. The firm’s total holdings are worth over $10.42 million and represent 3.8697% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are iShares Russell 2000 ETF and Vanguard Total Stock Market Index Fund . As of Sep 30, 2024 , the former fund manager holds about 2.06% shares in the company for having 892.6 shares of worth $5.66 million while later fund manager owns 838.53 shares of worth $5.32 million as of Jun 30, 2024 , which makes it owner of about 1.94% of company’s outstanding stock.